Analyst Ratings for Contineum Therapeutics (CTNM)
CTNM Rating Summary
CTNM Price Target Summary
- Highest: $29.00 (Stifel)
- Lowest: $14.00 (Morgan Stanley)
- Average: $22.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$22.00 (+58.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$22.00 (+58.5%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/8/2026 | Morgan Stanley | Jeffrey Hung | Downgrade | Equalweight (Overweight) |
14.00 (23.00) |
9.49 (13.88) |
46.26% | Details |
| 11/13/2025 | Leerink Partners | Roanna Ruiz | New Coverage | Outperform (N/A) |
22.00 (N/A) |
11.47 (13.88) |
21.01% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
